SEB Asset Management AB »

ResMed shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of ResMed (RMD) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $31M 140k 224.48

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding ResMed

Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Swedbank AB
Charles Schwab Investment Management
Amundi

View all funds holding ResMed